Classical Maple Syrup Urine Disease successfully treated with living donor liver transplantation

2021 ◽  
Vol 28 (4) ◽  
pp. 842
Author(s):  
Gulec Dogan ◽  
Sait Dogan ◽  
Gokalp Okut ◽  
Ahmet Sigirci ◽  
Sezai Yilmaz
Keyword(s):  
Liver Transplantation ◽  
Maple Syrup Urine Disease ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Maple Syrup ◽  
Donor Liver Transplantation ◽  
Urine Disease

scholarly journals Successful living donor liver transplantation for classical maple syrup urine disease

2016 ◽  
Vol 20 (5) ◽  
pp. 707-710 ◽  
Author(s):  
Toshihiro Yasui ◽  
Tatsuya Suzuki ◽  
Fujio Hara ◽  
Shunsuke Watanabe ◽  
Naoko Uga ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Maple Syrup Urine Disease ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Maple Syrup ◽  
Donor Liver Transplantation ◽  
Urine Disease

A case of classical maple syrup urine disease that was successfully managed by living donor liver transplantation

2017 ◽  
Vol 21 (5) ◽  
pp. e12948 ◽  
Author(s):  
Chika Takano ◽  
Mika Ishige ◽  
Erika Ogawa ◽  
Hiromi Usui ◽  
Reiko Kagawa ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Maple Syrup Urine Disease ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Maple Syrup ◽  
Donor Liver Transplantation ◽  
Urine Disease

Living donor liver transplantation from a heterozygous parent for classical maple syrup urine disease

2015 ◽  
Vol 19 (3) ◽  
pp. E66-E69 ◽  
Author(s):  
Masashi Kadohisa ◽  
Shirou Matsumoto ◽  
Hirotake Sawada ◽  
Masaki Honda ◽  
Takahiro Murokawa ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Maple Syrup Urine Disease ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Heterozygous Parent ◽  
Maple Syrup ◽  
Donor Liver Transplantation ◽  
Urine Disease

Heterozygote to homozygote related living donor liver transplantation in maple syrup urine disease: A case report

2015 ◽  
Vol 19 (3) ◽  
pp. E62-E65 ◽  
Author(s):  
N. Patel ◽  
J. Loveland ◽  
M. Zuckerman ◽  
P. Moshesh ◽  
R. Britz ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Case Report ◽  
Maple Syrup Urine Disease ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Maple Syrup ◽  
Donor Liver Transplantation ◽  
Urine Disease

Living donor liver transplantation in maple syrup urine disease - Case series and world's youngest domino liver donor and recipient

2016 ◽  
Vol 20 (3) ◽  
pp. 395-400 ◽  
Author(s):  
N. Mohan ◽  
S. Karkra ◽  
A. Rastogi ◽  
V. Vohra ◽  
A. S. Soin
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Case Series ◽  
Liver Donor ◽  
Donor Liver ◽  
Maple Syrup ◽  
Donor Liver Transplantation ◽  
Disease Case ◽  
Urine Disease

Living related versus deceased donor liver transplantation for maple syrup urine disease

2016 ◽  
Vol 117 (3) ◽  
pp. 336-343 ◽  
Author(s):  
Flavia Feier ◽  
Ida Vanessa D. Schwartz ◽  
Abigail R. Benkert ◽  
Joao Seda Neto ◽  
Irene Miura ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Maple Syrup Urine Disease ◽  
Deceased Donor ◽  
Donor Liver ◽  
Maple Syrup ◽  
Donor Liver Transplantation ◽  
Deceased Donor Liver Transplantation ◽  
Urine Disease ◽  
Living Related

Adult-to-Adult Living-Donor Liver Transplantation

Swiss Surgery ◽  
2003 ◽  
Vol 9 (5) ◽  
pp. 227-236 ◽  
Author(s):  
Majno ◽  
Mentha ◽  
Berney ◽  
Bühler ◽  
Giostra ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Therapeutic Option ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Multidisciplinary Program ◽  
First Case ◽  
Living Donor Transplantation ◽  
The Right

Living donor liver transplantation is a relatively new procedure in which the right side of the liver is harvested in a healthy donor and transplanted into a recipient. After the first case in 1994, over 3000 cases have been done worldwide. This review summarizes the reasons why the procedure is needed, describes its main technical aspects, highlights the boundaries in which it can be done safely, summarizes the current experience worldwide and describes the main points of the program in our unit. We argue that living-donor transplantation is a viable alternative to a long time on the waiting list for several patients, and it can be performed safely and successfully provided that all precautions are undertaken to minimize the risks in the donor and to increase the chances of a good outcome in the recipients. If these prerequisites are met, and within the framework of a structured multidisciplinary program, we believe that living-donor liver transplantation should be funded by health insurances as a recognized therapeutic option.

Sign in / Sign up

Export Citation Format

Share Document